Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SOTERA HEALTH COMPANY

(SHC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/26/2021 11/29/2021 11/30/2021 12/01/2021 12/02/2021 Date
21.68(c) 21.49(c) 21.34(c) 20.73(c) 20.96 Last
360 805 778 948 816 372 1 232 402 437 729 Volume
-1.05% -0.88% -0.70% -2.86% +1.11% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 926 M - -
Net income 2021 116 M - -
Net Debt 2021 1 694 M - -
P/E ratio 2021 50,2x
Yield 2021 -
Sales 2022 1 013 M - -
Net income 2022 214 M - -
Net Debt 2022 1 397 M - -
P/E ratio 2022 27,3x
Yield 2022 -
Capitalization 5 865 M 5 865 M -
EV / Sales 2021 8,16x
EV / Sales 2022 7,17x
Nbr of Employees 3 000
Free-Float 96,2%
More Financials
Company
Sotera Health Company. is a provider of sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The Company operates through three segments: Sterigenics, Nordion and Nelson Labs. The Sterilization Services includes products, such as procedure kits and trays, implants, syringes, catheters, wound care products, medical protective barriers, including personal protective... 
More about the company
Ratings of Sotera Health Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about SOTERA HEALTH COMPANY
11/29Clinical Laserthermia Systems AB Enters into Agreement with Two Additional Suppliers of..
CI
11/10SOTERA HEALTH CO Management's Discussion and Analysis of Financial Condition and Resul..
AQ
11/10Sotera Health Company Mulls M&A
CI
11/10Sotera Health Reports Third-Quarter and Year-to-Date 2021 Results - Form 8-K
PU
11/10SOTERA HEALTH CO : Results of Operations and Financial Condition (form 8-K)
AQ
11/10Sotera Health Q3 Adjusted Earnings, Net Revenue Increase; 2021 Guidance Range Narrowed
MT
11/10Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Reports Q3 Revenue $226.2M, vs. Street ..
MT
11/10Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Reports Q3 EPS $0.21, vs. Street Est of..
MT
11/10Sotera Health Reports Third-Quarter and Year-to-Date 2021 Results
AQ
11/10Sotera Health Company Provides Earnings Guidance for the Full-Year 2021
CI
11/10SOTERA HEALTH : Announces Acquisition of Wisconsin-Based Regulatory Compliance Associates
PU
11/09Sotera Health Company acquired Regulatory Compliance Associates Inc.
CI
10/15SOTERA HEALTH : Announces Q3 2021 Earnings Release Date
AQ
09/28SOTERA HEALTH : Nelson Labs« and Sterigenics« Open State-of-the-Art Laboratory and Expand ..
AQ
08/27SOTERA HEALTH CO : Termination of a Material Definitive Agreement (form 8-K)
AQ
More news
News in other languages on SOTERA HEALTH COMPANY
11/10Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC annonce un chiffre d'affaires de 226,2 ..
11/10Sotera Health Company fournit des prévisions de résultats pour l'ensemble de l'année 20..
09/28SOTERA HEALTH : Nelson Labs« et Sterigenics« ouvrent un laboratoire ultramoderne et étende..
09/28SOTERA HEALTH : Nelson Labs« und Sterigenics« eröffnen hochmodernes Labor und erweitern St..
09/28Nelson Labs« et Sterigenics« ouvrent un laboratoire ultramoderne et étendent leurs inst..
More news
Analyst Recommendations on SOTERA HEALTH COMPANY
More recommendations
Chart SOTERA HEALTH COMPANY
Duration : Period :
Sotera Health Company Technical Analysis Chart | SHC | US83601L1026 | MarketScreener
Technical analysis trends SOTERA HEALTH COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 20,73 $
Average target price 31,75 $
Spread / Average Target 53,2%
EPS Revisions
Managers and Directors
Michael B. Petras Chairman & Chief Executive Officer
Scott J. Leffler Chief Financial Officer & Treasurer
Robert G. Hauzie Chief Information Officer
Sean Laurence Cunningham Independent Director
Dave Anthony Donnini Independent Director